`

Minoryx Therapeutics

Biotechnology

Specialities :
Rare diseases
Neurometabolic diseases
X-linked adrenoleukodystrophy
Friedreich's ataxia
And orphan cns
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About Minoryx Therapeutics

What does Minoryx therapeutics do?+

Minoryx is a registration stage biotech company focusing on the development of novel therapies for orphan CNS diseases with high unmet medical needs. The companys lead program, leriglitazone (MIN-102), a novel, brain penetrant and selective PPAR gamma agonist, is being developed in X-linked Adrenoleukodystrophy (X-ALD) and other orphan CNS diseases. The company is backed by a syndicate of experienced investors, which includes Columbus Venture Partners, CDTI Innvierte, Caixa Capital Risc, Fund+, Ysios Capital, Roche Venture Fund, Kurma Partners, Chiesi Ventures, S.R.I.W, Idinvest Partners / Eurazeo, SFPI-FPIM, HealthEquity, Sambrinvest and Herrecha, and has support from a network of other organizations. Minoryx...

What are Minoryx therapeutics's specialties? +

Rare diseases,neurometabolic diseases,x-linked adrenoleukodystrophy,friedreich's ataxia,and orphan cns

What is Minoryx therapeutics's industry? +

Minoryx therapeutics operates in the Biotechnology industry.

What is Minoryx therapeutics's revenue? +

Minoryx therapeutics's revenue is 11m - 100m

What is Minoryx therapeutics's company size? +

Minoryx therapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.